Oropharyngeal bacterial pathogens

Oropharyngeal bacterial pathogens comprise a diverse group of microorganisms that inhabit the human pharynx and are capable of causing significant respiratory and systemic diseases. Common members include Streptococcus pyogenes (Group A Streptococcus), Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis [StatPearls: Pharyngitis, 2023]. These pathogens utilize specialized virulence factors, such as polysaccharide capsules and secreted toxins, to colonize mucosal surfaces and bypass host immune defenses [NIH: Oropharyngeal Microbiota, 2018]. While many of these bacteria can exist as commensals, their overgrowth or the introduction of virulent strains leads to infections like pharyngitis, tonsillitis, and pneumonia. Treatment typically involves antibiotic therapy targeting bacterial cell wall integrity or protein synthesis machinery [Merck Manual: Antibacterial Drugs, 2022]. However, the increasing prevalence of antibiotic resistance among these pathogens represents a major therapeutic challenge, necessitating careful diagnostic stewardship and the development of alternative treatments like vaccines or narrow-spectrum antimicrobials.

Other names

Pharyngeal pathogensThroat bacteriaOropharyngeal flora (pathogenic)Upper respiratory tract bacterial pathogens

Inhibition of cell wall synthesis (via penicillin-binding proteins), Inhibition of protein synthesis (via 50S or 30S ribosomal subunits), Inhibition of DNA replication (via DNA gyrase/topoisomerase IV).